How tirzepatide works Tirzepatide is a dual GLP-1/GIP receptor agonist used to treat type 2 diabetes and chronic weight management
Typical timeline: Reduced appetite within weeks Gradual weight loss over months Continued improvement with consistent treatment Results vary based on individual metabolism and lifestyle
Use of GLP-1RAs, DPP-4is or amylin analogues as rescue medication was not permitted
GLP-1 is mainly produced in the enteroendocrine L cells located in the distal intestine exerting its effects through binding to the GLP-1 receptors (GLP-1R) expressed in the pancreas, heart, blood vessels, gastrointestinal tract (GIT), kidney, lung, breast, and central nervous system [11],[12]
Administration and claims processing happen outside Part D plans
Click to learn more about the cost of semaglutide with BMI Doctors program